期刊文献+

临床药师干预对急性脑梗死介入术后患者用药依从性及疗效的影响 被引量:9

Effect of clinical pharmacist intervention on drug compliance and efficacy of patients after acute cerebral infarction
原文传递
导出
摘要 目的探讨临床药师干预对急性脑梗死介入术后患者用药疗效及依从性的影响。方法将73例急性脑梗死并进行介入术治疗的患者随机分为对照组36例和试验组37例。出院时,对照组采用常规的护士发药和简单宣讲方式;试验组由临床药师进行用药干预指导。半年后,随诊并评价2组患者的用药效果及依从性。结果试验组和对照组的总有效率分别为70.27%(26/37例)和47.22%(17/36例);掌握用药方法的总体合格率分别为78.38%(29/37例)和52.78%(19/36例);用药依从性较好率分别为56.76%(21/37例)和30.56%(11/36例);自动停药率分别为0(0/37例)和19.44%(7/36例),差异均有统计学意义(均P<0.05)。结论临床药师干预可明显提高急性脑梗死介入术后患者的治疗效果,提高患者对用药方法的掌握程度和用药依从性。 Objective To analyze effect of clinical pharmacist intervention on drug compliance and efficacy of patients after acute cerebral in- farction. Methods A total of 73 patients with acute cerebral infarction and intervention were randomly divided into control group (36 cases) and treatment group (37 cases). At the time of discharge, the control group adopted conventional nurse dispensing and short - answer presentation mode. The treatment group was instructed by the clinical pharma- cist. Six months later, follow - up and evaluation of the two groups of patients with drug effects and compliance. Results The total effective rate was 70. 27% (26/37 cases) and 47.22% (17/36 cases) in the treat- ment group and the control group, respectively. The overall pass rate of the mastery of medication was 78.38% (29/37 cases) and 52.78% ( 19/36 cases). The rate of drug withdrawal was 56. 76% ( 21/37 cases) and 30. 56% ( 11/36 cases) respectively. The rates of automatic withdrawal were 0 (0/37 cases) and 19. 44% (7/36 cases) There was statistical significance (P 〈 0. 05 ). Conclusion Clinical pharmacist in- tervention can significantly improve the therapeutic effect of patients with acute cerebral infarction after intervention, which improve the degree of medication and medication compliance.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第10期939-941,共3页 The Chinese Journal of Clinical Pharmacology
基金 河北省卫计委青年科技课题基金资助项目(20110368)
关键词 临床药师干预 急性脑梗死介入术 用药疗效 用药依从性 clinical pharmacist intervention acute cerebral infarction intervention drug efficacy medication compliance
  • 相关文献

参考文献2

二级参考文献26

  • 1Magro M. Acute coronary syndromes: No-reflow--an ominous sign of cardiac dysfunction. Nat reviews. Cardiol, 2010,7 480-482.
  • 2洪涛.冠状动脉TIMI血流分级.中国介入心脏病学杂志,2003,11:154.
  • 3Skyschally A,Schulz R, Heusch G. Pathophysiology of myocardial infarction. Herz, 2008,33 : 88-100.
  • 4Niccoli G, Kharbanda RK. No-reflow: again prevention is better than treatment. Euro Heart J, 2010,31 : 2449-2455.
  • 5Valgimigli M, Biondi Z. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a recta-analysis of randomized trials. Euro Heart J, 2010, 31 ..35-49. Li YC,Chen YQ. Efficacy of domestic low dose.
  • 6van Domburg RT, Foley DP, de Feyter PJ, et al. Long-term clini- cal outcome after coronary balloon angioplasty :identification of a population at low risk of recurrent events during 17 years of follow- up [J]. Eur Heart J, 2001,22(11) :934-941.
  • 7Hannan EL, Racz M J, Arani DT, et al. A comparison of short- and long-term outcomes for balloon angioplasty and coronary stent placement [ J ]. J Am Coil Cardiol, 2000,36 (2) :395-403.
  • 8Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unsta- ble coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa in- hibitor tirofiban [ J]. N Engl J Med, 2001,344(25 ) : 1939-1942.
  • 9ACC/AHA guidelines of percutaneous coronary interventions ( re- vision of the 1993 PTCAguidelines) executive summary. A re- port of the American College of Cardiology/AmericanHeart Associ- ation Task Force on Practice Guidelines (committee to revise the 1993guidelines for percutaneous transluminal coronary angioplas- ty) [J]. J Am Coil Cardiol, 2001,37(8) :2215-2239.
  • 10Kolh P, Wijns W, Danchin N, et al. Guidelines on myocardial revascularization [ J ]. Eur Heart J, 2010,31 ( 20 ) : 2501-2555.

共引文献36

同被引文献95

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部